Double-Blind, Placebo-Controlled, Crossover Study With Roll-over Extension of Two RE03 Doses for PTSD Sleep Disturbances

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2024
Post-traumatic stress disorder (PTSD) affects many people who have experienced traumatic events. A common issue with PTSD is severe sleep disturbances, such as nightmares. Current treatments often do not provide sufficient relief, especially for sleep problems. This study aims to determine whether dexmedetomidine - a medication already used in intensive care - can improve sleep quality in PTSD patients and be safely administered both in the sleep lab and in the patient\'s natural environment.
Epistemonikos ID: 79c2f50ec6e0dacb2829f3b814e312d75e542cbb
First added on: Dec 01, 2024